Consortium dedicated to launching a healthcare system-wide “learning engine” for rheumatoid arthritis in Massachusetts The Arthritis Foundation has joined the NEWDIGS Initiative at the Massachusetts Institute of Technology Center for … Read More
Payer Perspectives Survey
A survey of 77 payers representing over 280 million lives, completed in April 2019, explored perspectives concerning financing challenges and management strategies associated with durable cell and gene therapies. Download … Read More
Gigi Hirsch speaks about Dynamic Dossier in the Cloud project at Sanofi
On June 11, 2019, MIT Center for Biomedical Innovation Executive Director Gigi Hirsch, MD, addressed the 4th Regulatory Innovation Evening held at Sanofi. This event brings pharmaceutical and regulatory professionals together … Read More
Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System
Value in Health, June 2019Casey Quinn, Colin Young, Jonathan Thomas, and Mark Trusheim Cell and gene therapies promise durable clinical benefit from a single treatment course. High upfront reimbursement for … Read More
Are Payers Ready, Willing, and Able to Provide Access to New Durable Gene Therapies?
Value in Health, June 2019Jane F. Barlow, Mo Yang, and J. Russell Teagarden Access to new gene therapies may be impacted by payer ability to absorb the cost of coverage. … Read More
American College of Rheumatology joins NEWDIGS LEAPS Project
Initiative to design a systemwide “learning engine” for rheumatoid arthritis in Massachusetts The American College of Rheumatology (ACR), an international medical association that serves more than 8,500 members of the … Read More
Massachusetts Pilot Disease Selection
Rheumatoid Arthritis (RA) chosen as target for LEAPS Massachusetts (MA) Pilot (RAMA) to demonstrate the feasibility and impact of a sustainable and patient-centered healthcare learning ecosystem to optimize care regimens … Read More
Pediatric Gene Therapy Launches
Gene therapy cures for hereditary genetic conditions are likely to reach the United States market in the coming decades. Several disease areas with potential cures are orphan conditions, which affect … Read More
Patient & Caregiver Themes Survey
Patients and caregivers are key stakeholders in the development of system-wide, implementable precision financing models for durable and curative therapies. Patient and caregiver challenges are generally assumed to be primarily … Read More